Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Elevance Health Inc
ELV | US
344.76
USD-1.53
-0.44%
ELV | US
About Elevance Health Inc
Sector
Healthcare
Industry
Healthcare Plans
Earnings date
30/09/2024
As of date
24/04/2026
Close
344.76
Open
348.00
High
350.79
Low
342.75
Elevance Health Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business Government Business CarelonRx and Other. It supports consumers families and communities across the entire care journey connecting to the care support and resources to lead healthier lives. It serves people through a portfolio of medical digital pharmacy behavioral clinical and care solutions. The company was formerly known as Anthem Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is based in Indianapolis Indiana.
View LessELV | US
Risk
30.4
Sharpe
-0.56
Luna's Score
54/100
Recommendation
Hold
Luna says (ELV | US)
What's Working
Positive Momentum
Largecap (10B - 200B USD)
Value Stock (Price to Book < 3)
What's not Working
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
34.1%1 month
30.4%3 months
45.1%6 months
38.2%Returns
Fundamental Ratios
PE
15.68
Fwd. PE
10.65
Price to book
2.35
Debt to equity
0.62
Debt to assets
0.23
Ent. to EBITDA
-
Ent. to rev.
0.70
PEG
0.66
Other Fundamentals
EBITDA
11.35B
MarketCap
79.96B
MarketCap(USD)
79.96B
Div. yield
1.51
Op. margin
4.39
Erngs. growth
-20.00
Rev. growth
5.40
Ret. on equity
15.50
Short ratio
2.55
Short perc.
1.04
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
44.49
Range1M
68.33
Range3M
103.60
Volumes: Market Activity
Rel. volume
0.96
Price X volume
562.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | 0.70 | - | Cheaper |
| PE Ratio | 15.68 | 16.55 | Par |
| Price to Book | 2.35 | 4.09 | Cheaper |
| Dividend Yield | 1.51 | - | Poor |
| Std. Deviation (3M) | 45.09 | - | Lower Risk |
| Debt to Equity | 0.62 | 1.40 | Cheaper |
| Debt to Assets | 0.23 | 0.26 | Par |
| Market Cap | 79.96B | - | Market Leader |
